Samantha A. Hershenfeld, Josuha W.D. Tobin, Victoria Shelton, Lourdes Calvente, Katherine Lajkosz, Ting Liu, Marianne Brodtkorb, Francesco Annibale d'Amore, Maja Ludvigsen, Tara Baetz, David LeBrun, Nathalie Johnson, Michael Crump, Michael Hong, John Kuruvilla, Rosemarie Tremblay-LeMay, Michael MacManus, Richard Tsang, David C. Hodgson, Maher K. Gandhi, Robert Kridel
{"title":"接受放射治疗的局限期滤泡性淋巴瘤的单基因突变与预后。","authors":"Samantha A. Hershenfeld, Josuha W.D. Tobin, Victoria Shelton, Lourdes Calvente, Katherine Lajkosz, Ting Liu, Marianne Brodtkorb, Francesco Annibale d'Amore, Maja Ludvigsen, Tara Baetz, David LeBrun, Nathalie Johnson, Michael Crump, Michael Hong, John Kuruvilla, Rosemarie Tremblay-LeMay, Michael MacManus, Richard Tsang, David C. Hodgson, Maher K. Gandhi, Robert Kridel","doi":"10.1111/bjh.19698","DOIUrl":null,"url":null,"abstract":"<p>Radiotherapy is routinely used for management of limited-stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We performed targeted sequencing of a 69-gene panel in 117 limited-stage FL patients treated with radiotherapy and identified recurrently mutated genes. <i>CREBBP</i> was most frequently mutated, and mutated <i>CREBBP</i> was associated with inferior progression-free survival, though not after false discovery rate adjustment. This association failed to validate in an independent cohort. We conclude that recurrent gene mutations do not predict outcomes in this setting. Alternative biomarkers may offer better prognostic insight.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":"205 5","pages":"1810-1814"},"PeriodicalIF":5.1000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.19698","citationCount":"0","resultStr":"{\"title\":\"Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy\",\"authors\":\"Samantha A. Hershenfeld, Josuha W.D. Tobin, Victoria Shelton, Lourdes Calvente, Katherine Lajkosz, Ting Liu, Marianne Brodtkorb, Francesco Annibale d'Amore, Maja Ludvigsen, Tara Baetz, David LeBrun, Nathalie Johnson, Michael Crump, Michael Hong, John Kuruvilla, Rosemarie Tremblay-LeMay, Michael MacManus, Richard Tsang, David C. Hodgson, Maher K. Gandhi, Robert Kridel\",\"doi\":\"10.1111/bjh.19698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Radiotherapy is routinely used for management of limited-stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We performed targeted sequencing of a 69-gene panel in 117 limited-stage FL patients treated with radiotherapy and identified recurrently mutated genes. <i>CREBBP</i> was most frequently mutated, and mutated <i>CREBBP</i> was associated with inferior progression-free survival, though not after false discovery rate adjustment. This association failed to validate in an independent cohort. We conclude that recurrent gene mutations do not predict outcomes in this setting. Alternative biomarkers may offer better prognostic insight.</p>\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\"205 5\",\"pages\":\"1810-1814\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2024-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.19698\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bjh.19698\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bjh.19698","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy
Radiotherapy is routinely used for management of limited-stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We performed targeted sequencing of a 69-gene panel in 117 limited-stage FL patients treated with radiotherapy and identified recurrently mutated genes. CREBBP was most frequently mutated, and mutated CREBBP was associated with inferior progression-free survival, though not after false discovery rate adjustment. This association failed to validate in an independent cohort. We conclude that recurrent gene mutations do not predict outcomes in this setting. Alternative biomarkers may offer better prognostic insight.
期刊介绍：
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
